Perioperative Management for Patients Taking DOACs - Frankly Speaking EP 230Guest: Robert A. Baldor, MD, FAAFP
Music Credit: Richard Onorato

Join us to discuss the results of the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) cohort study, aimed at understanding the safety of using a simplified perioperative management approach for patients with atrial fibrillation taking DOACs. After this episode, you’ll be able to make sense of the controversy over current guidelines around surgical care in this patient population. More importantly, you’ll walk away with practical knowledge to help these patients minimize their risk of adverse events.

Episode References and Resources:

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med.2019; 179(11 ): 1469-14 78. doi: 10.1001 /jamainternmed.2019.2431

Begin

Already listened on another platform?

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 6/28/2021

Expiration Date: 6/28/2022

Topics

Learning Objectives

Describe the controversary over current guidelines for the surgical care of patients taking direct oral anticoagulants (DOACs) for atrial fibrillation
Interpret the data on the efficacy and safety of a simplified approach to the perioperative management of patients taking DOACs for atrial fibrillation
Clarify the pre-operative assessment and advice for patients with atrial fibrillation who are taking DOACs to minimize their risks of adverse events

Faculty

Frank J. Domino, MD

Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA

Learn More

Robert A. Baldor, MD, FAAFP

Professor and Chairman, Dept of Family Medicine
UMass Medical School/Baystate

Learn More

Supported by

Not Applicable

Education Partner

Not Applicable